The Washington Post's Philip Bump looks at how Fox coverage of hydroxychloroquine has changed as studies have countered the White House's original enthusiasm for the drug.
WashPost: Trump And Fox News Suggest Caution On Hydroxychloroquine Studies (After One Undercuts Their Case)
